4 months ago
27
SHIRLEY, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company”) (TSXV: EVMT) is pleased to announce that the Company's Board of Directors has approved the grant of 1,000,000 restricted stock units (RSUs) to William Garbarini in connection with his appointment as Chief Operating Officer, effective November 22, 2024.
The RSUs were granted under the Company's Amended and Restated 2023 Equity Incentive Plan, will vest over a period of 24 months, and upon vesting will be settled in common shares of the Company. The RSUs and underlying common shares are subject to a four month and one day hold period pursuant to Canadian securities laws and the policies of the TSX Venture Exchange.
For more information please contact:
Mike Seckler
Chief Executive Officer
Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
Tel: 1 (800) 760-6826
Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
